PhillipsPGalanisEMacDougallL, et al; British Columbia Cryptococcus gattii Study Group. Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia. Clin Infect Dis. 2015;60:1368-1376. doi:10.1093/cid/civ041
3.
SeatonRANaraqiSWembriJPWarrellDA.Predictors of outcome in Cryptococcus neoformans var gattii meningitis. QJM. 1996;89:423-428. doi:10.1093/qjmed/89.6.423
4.
MorganJMcCarthyKMGouldS, et al; Gauteng Cryptococcal Surveillance Initiative Group. Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002-2004. Clin Infect Dis. 2006;43:1077-1080. doi:10.1086/507897
5.
SeatonRAVermaNNaraqiSWembriJPWarrellDA.Visual loss in immunocompetent patients with Cryptococcus neoformans var gattii meningitis. Trans R Soc Trop Med Hyg. 1997;91:44-49. doi:10.1016/s0035-9203(97)90391-6
6.
ChangaARCzeislerBMLordAS.Management of elevated intracranial pressure: a review. Curr Neurol Neurosci Rep. 2019;19:99. doi:10.1007/s11910-019-1010-3
7.
Rangel-CastillaLGopinathSRobertsonCS.Management of intracranial hypertension. Neurol Clin. 2008;26:521-541,x. doi:10.1016/j.ncl.2008.02.003
8.
WalkerCTStoneJJJacobsonMPhillipsVSilbersteinHJ.Indications for pediatric external ventricular drain placement and risk factors for conversion to a ventriculoperitoneal shunt. Pediatr Neurosurg. 2012;48:342-347. doi:10.1159/000353608
9.
NagDSSahuSSwainAKantS.Intracranial pressure monitoring: gold standard and recent innovations. World J Clin Cases. 2019;7:1535-1553. doi:10.12998/wjcc.v7.i13.1535
10.
ZhangQLiHZhangK, et al. Lumbar drainage for the treatment of refractory intracranial hypertension in HIV-negative cryptococcal meningitis. Future Microbiol. 2019;14:859-866. doi:10.2217/fmb-2019-0084
11.
Lo ReV3rdGluckmanSJ.Eosinophilic meningitis. Am J Med. 2003;114:217-223. doi:10.1016/s0002-9343(02)01495-x
